196 related articles for article (PubMed ID: 31101331)
1. [Hydrochlorothiazide use and risk of skin cancers: A systematic review].
Becquart O; Guillot B; Bourrain JL; Duflos C; Du-Thanh A
Rev Med Interne; 2019 Sep; 40(9):617-622. PubMed ID: 31101331
[TBL] [Abstract][Full Text] [Related]
2. In Brief: Hydrochlorothiazide and skin cancer.
Med Lett Drugs Ther; 2020 Nov; 62(1611):177. PubMed ID: 33429413
[No Abstract] [Full Text] [Related]
3. Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients.
Letellier T; Leborgne F; Kerleau C; Gaultier A; Dantal J; Ville S;
Clin J Am Soc Nephrol; 2020 Dec; 15(12):1804-1813. PubMed ID: 33172936
[TBL] [Abstract][Full Text] [Related]
4. Hydrochlorothiazide use and risk of non-melanoma skin cancer in Spain: A case/non-case study.
Lecaros-Astorga DA; Molina-Guarneros JA; Rodríguez-Jiménez P; Martin-Arias LH; Sainz-Gil M
Int J Clin Pharmacol Ther; 2021 Apr; 59(4):280-288. PubMed ID: 33355085
[TBL] [Abstract][Full Text] [Related]
5. Hydrochlorothiazide treatment and risk of non-melanoma skin cancer: Review of the literature.
Garrido PM; Borges-Costa J
Rev Port Cardiol (Engl Ed); 2020 Mar; 39(3):163-170. PubMed ID: 32354458
[TBL] [Abstract][Full Text] [Related]
6. [Hydrochlorothiazide and skin cancer].
Olde Engberink RHG; van der Hoeven NV; Zwinderman AH; van den Born BH
Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120217
[TBL] [Abstract][Full Text] [Related]
7. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark.
Pedersen SA; Gaist D; Schmidt SAJ; Hölmich LR; Friis S; Pottegård A
J Am Acad Dermatol; 2018 Apr; 78(4):673-681.e9. PubMed ID: 29217346
[TBL] [Abstract][Full Text] [Related]
8. Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control study.
Adalsteinsson JA; Muzumdar S; Waldman R; Hu C; Wu R; Ratner D; Ungar J; Silverberg JI; Olafsdottir GH; Kristjansson AK; Tryggvadottir L; Jonasson JG
J Am Acad Dermatol; 2021 Mar; 84(3):669-675. PubMed ID: 32791082
[TBL] [Abstract][Full Text] [Related]
9. Associations of thiazide use with skin cancers: a systematic review and meta-analysis.
Shao SC; Lai CC; Chen YH; Lai EC; Hung MJ; Chi CC
BMC Med; 2022 Jul; 20(1):228. PubMed ID: 35794547
[TBL] [Abstract][Full Text] [Related]
10. Increased cutaneous squamous cell carcinoma risk with hydrochlorothiazide use: is there a safe alternative?
Hollestein LM; Arnspang Pedersen S
Br J Dermatol; 2021 Aug; 185(2):244-245. PubMed ID: 34224145
[No Abstract] [Full Text] [Related]
11. Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study.
Haisma MS; Greven N; Logendran M; Bos J; van der Vegt B; Horváth B; De Vos S; De Bock GH; Hak E; Rácz E
Acta Derm Venereol; 2023 Apr; 103():adv3933. PubMed ID: 37014269
[TBL] [Abstract][Full Text] [Related]
12. Hydrochlorothiazide use is associated with the risk of cutaneous and lip squamous cell carcinoma: A systematic review and meta-analysis.
de Macedo Andrade AC; Felix FA; França GM; Ribeiro ILA; Barboza CAG; de Castro RD; de Lisboa Lopes Costa A
Eur J Clin Pharmacol; 2022 Jun; 78(6):919-930. PubMed ID: 35258665
[TBL] [Abstract][Full Text] [Related]
13. Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study.
Pottegård A; Pedersen SA; Schmidt SAJ; Lee CN; Hsu CK; Liao TC; Shao SC; Lai EC
Br J Cancer; 2019 Nov; 121(11):973-978. PubMed ID: 31673105
[TBL] [Abstract][Full Text] [Related]
14. Iatrogenic immunosuppression and cutaneous malignancy.
DePry JL; Reed KB; Cook-Norris RH; Brewer JD
Clin Dermatol; 2011; 29(6):602-13. PubMed ID: 22014982
[TBL] [Abstract][Full Text] [Related]
15. Use of antihypertensive drugs and risk of skin cancer.
Schmidt SA; Schmidt M; Mehnert F; Lemeshow S; Sørensen HT
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1545-54. PubMed ID: 25640031
[TBL] [Abstract][Full Text] [Related]
16. Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population-based nested case-control studies.
Morales DR; Pacurariu A; Slattery J; Kurz X
Br J Clin Pharmacol; 2020 Jul; 86(7):1336-1345. PubMed ID: 32068906
[TBL] [Abstract][Full Text] [Related]
17. Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer.
Rouette J; Yin H; Pottegård A; Nirantharakumar K; Azoulay L
Drug Saf; 2021 Feb; 44(2):245-254. PubMed ID: 33104975
[TBL] [Abstract][Full Text] [Related]
18. Hydrochlorothiazide use and risk for Merkel cell carcinoma and malignant adnexal skin tumors: A nationwide case-control study.
Pedersen SA; Johannesdottir Schmidt SA; Hölmich LR; Friis S; Pottegård A; Gaist D
J Am Acad Dermatol; 2019 Feb; 80(2):460-465.e9. PubMed ID: 29913261
[TBL] [Abstract][Full Text] [Related]
19. [Puva therapy and carcinogenesis].
Thomas P; Pannequin C
Ann Dermatol Venereol; 1991; 118(6-7):503-6. PubMed ID: 1897842
[No Abstract] [Full Text] [Related]
20. Hydrochlorothiazide Use and Increased Squamous Cell Carcinoma Burden in a High-Risk Mohs Population: A Cross-Sectional Study.
Han S; Wolfe CM; Angnardo L; Pedersen SA; Gaist D; Pottegård A; Cognetta AB
Dermatol Surg; 2020 May; 46(5):704-708. PubMed ID: 30865018
[No Abstract] [Full Text] [Related]
[Next] [New Search]
